NasdaqGS:UTHRBiotechs
Assessing United Therapeutics (UTHR) Valuation After Recent Share Price Swings
Why United Therapeutics (UTHR) is on investors’ radar today
United Therapeutics (UTHR) has drawn attention after recent share price swings, with a 1 day decline and mixed returns over the month and past 3 months prompting investors to reassess the stock’s current setup.
At a last close of US$468.94, the biotech group sits against a backdrop of longer term total returns over the past year and multi year period, alongside double digit annual revenue and net income growth, which together shape...